OQROGet OQRO Pro
Politician trade (House)

Abbott Laboratories (ABT)Rep. John Curtis (UT03) disclosed a sale $1K–$15K

Rep. John Curtis (UT03) disclosed a sale of Abbott Laboratories in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
11 days
Disclosure lag
Traded
Dec 4, 2023
Disclosed
Dec 15, 2023

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 13, 2023CongressDisclosed purchase of ABT — reported range $15,001 - $50,000
  2. Sep 21, 2023CongressDisclosed sale of ABT — reported range $100,001 - $250,000
  3. Sep 26, 2023CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
  4. Oct 3, 2023CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
  5. Oct 19, 2023FDARecall: Alinity i Processing Module REF 03R65-01 The Alinity i Processing Module is a fully automated immunoassay analyzer allowing random and continuous access, as we…
  6. Oct 24, 2023CongressDisclosed sale of ABT — reported range $1,001 - $15,000
  7. Oct 30, 2023FDARecall: Alinity m HCV AMP kit, List (REF) Numbers: a) 08N50-095 and b) 08N50-090. The Alinity m HCV assay is an in vitro reverse transcription-polymerase chain reactio…
  8. Oct 31, 2023FDARecall: Similac Probiotic Tri-Blend - 0.017oz (0.50g) packaged in foil packets. 50 foil packets per carton - 3 cartons per case.
  9. Nov 1, 2023FDAFDA device approval: Alinity m HR HPV
  10. Dec 4, 2023 · this disclosureCongressDisclosed sale of ABT — reported range $1,001 - $15,000

What came next

  1. Dec 18, 2023FDARecall: TactiFlex Ablation Sensor Enabled Ablation Catheter, Models A-TFSE-FJ, 7.5 F shaft and an 8F distal section, Sterile.
  2. Dec 19, 2023FDAFDA device clearance: JETi™Hydrodynamic Thrombectomy System
  3. Jan 17, 2024CongressDisclosed partial sale of ABT — reported range $1,001 - $15,000
  4. Jan 23, 2024Congress · 1 personMembers of Congress: 2 sales
  5. Jan 26, 2024FDAFDA device clearance: CentriMag™ Acute Circulatory Support System
  6. Feb 1, 2024FDARecall: Wash station: M1000 Wash Station Assembly & DITI Slide, REF 04J72-28* (*This part number is a spare to the M2000sp.)
  7. Feb 1, 2024FDARecall: In-vitro diagnostic kits: (1) Abbott Vysis MDM2 / CEP 12 FISH Probe Kit, REF 01N15-010; (2) Abbott Vysis LSI D13S319 (13q14.3) SpectrumOrange Probe, REF 01N34-…
  8. Feb 1, 2024FDARecall: In-vitro diagnostic kits: (1) Abbott Vysis LSI ATM (11q22.3) SpectrmOrange Probe, REF 01N33-020; (2) Abbott Vysis PTEN/CEP 10 FISH Probe Kit, REF 04N62-020; (3…
  9. Feb 5, 2024FDARecall: Abbott Aveir Leadless Pacemaker, REF: LSP112V, STERILEEO
  10. Feb 21, 2024FDARecall: ARCHITECT STAT Myoglobin Reagent Kit, LN 2K43-25 and 2K43-20.
  11. Mar 1, 2024FDARecall: Abbott Cholestech LDX Battery Kit, Model: 3LP656194-PCM-LD, PN: 55170
  12. Mar 20, 2024FDARecall: Alinity m System, Part Number: 08N53-002
  13. Apr 1, 2024FDAFDA device approval: TriClip G4 System
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Abbott Laboratories

For Abbott Laboratories, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports and 82 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ABT page.

Other recent filings by Rep. John Curtis (UT03)

The full history of Rep. John Curtis (UT03) is on the profile page.

How this filing works

Other disclosures at Abbott Laboratories

Everything OQRO holds on this company is on its ABT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data